UBE2M is a NEDD8-conjugating enzyme (E2) that catalyzes the covalent attachment of NEDD8 to target proteins in the neddylation pathway 1. The enzyme specifically interacts with E3 ligase RBX1 to form the UBE2M-RBX1 complex, which neddylates cullin proteins including CUL1, CUL2, CUL3, and CUL4, thereby activating Cullin-RING E3 ligases (CRLs) 2. UBE2M activity requires both an N-terminal docking peptide and a conserved E2 catalytic core domain for NEDD8 transfer 1. The enzyme plays critical roles in immune regulation, particularly in maintaining regulatory T cell homeostasis and controlling double-negative T cell apoptosis through Bim degradation pathways 23. In cancer contexts, UBE2M promotes tumor progression through multiple mechanisms, including activation of β-catenin/cyclin D1 signaling in hepatocellular carcinoma and formation of positive feedback loops with estrogen receptor α in breast cancer 45. UBE2M function can be enhanced by post-translational modifications such as PRMT1-mediated arginine methylation, which affects metabolic pathways in kidney injury 6. The enzyme represents a promising therapeutic target, with inhibitors like MLN4924 showing efficacy in treating renal cell carcinoma and other malignancies 7.